Evaluation of rimegepant utilization patterns and patient characteristics among new users: a United States administrative claims-based study
Our analysis provides the first real-world data available on tablet utilization and characteristics of new users of rimegepant.
Authors
- Motomori O. Lewis (ORCID: https://orcid.org/0000-0001-5533-0830)
- Jessica Cirillo
- Karin Hygge Blakeman (ORCID: https://orcid.org/0000-0001-6925-7099)
- Joshua David Brown (ORCID: https://orcid.org/0000-0002-2973-1021)
- Lucy Abraham (ORCID: https://orcid.org/0000-0003-1648-8621)
- Jessica Ailani (ORCID: https://orcid.org/0000-0001-8106-4927)
- Aaron Jenkins (ORCID: https://orcid.org/0000-0001-9785-9388)
- Feng Dai (ORCID: https://orcid.org/0000-0002-9963-6863)
Institutions
- Pfizer (United States) (US)
- Georgetown University (US)
- Pfizer (United Kingdom) (GB)
- MedStar Georgetown University Hospital (US)
- Pfizer (Sweden) (SE)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1080/03007995.2024.2410930
- Citations
- 3
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16